Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.9B | 2.3B | 2.4B |
Cost of revenue | 1.4B | 2.0B | 1.5B | 1.5B |
Gross profit | 719M | 980M | 827M | 875M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 383M | 477M | 405M | 418M |
Other operating expenses | 163M | 201M | 175M | 178M |
Operating income | 71M | 209M | 152M | 183M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 112M | 115M | 117M | 119M |
Other income expense | -62M | -1.5B | -35M | -17M |
Pretax income | -103M | -1.4B | 0 | 47M |
Tax provision | -12M | -94M | 15M | 15M |
Net income | -91M | -1.3B | -15M | 32M |
Basic EPS | -0.3 | — | -0.1 | 0.1 |
Diluted EPS | -0.3 | — | -0.1 | 0.1 |
Basic average shares | 400M | — | 396M | 396M |
Diluted average shares | 401M | — | 397M | 397M |
EBITDA | 175M | 317M | 234M | 275M |
Net income from continuing op. | -91M | -1.3B | -15M | 32M |
Minority interests | -9M | -11M | -8M | -12M |
Preferred stock dividends | — | — | — | — |